Free Trial

Abingdon Health (ABDX) Competitors

Abingdon Health logo
GBX 7.75
0.00 (0.00%)
(As of 11/1/2024 ET)

ABDX vs. AGL, YGEN, GDR, VRCI, PRM, GENI, IDHC, LLAI, DMTR, and LLA

Should you be buying Abingdon Health stock or one of its competitors? The main competitors of Abingdon Health include ANGLE (AGL), Yourgene Health (YGEN), genedrive (GDR), Verici Dx (VRCI), Proteome Sciences (PRM), GENinCode (GENI), Integrated Diagnostics (IDHC), LungLife AI (LLAI), Deepmatter Group (DMTR), and LLA.L,0P0001T9GN,0 (LLA). These companies are all part of the "diagnostics & research" industry.

Abingdon Health vs.

Abingdon Health (LON:ABDX) and ANGLE (LON:AGL) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment, analyst recommendations and community ranking.

In the previous week, Abingdon Health's average media sentiment score of 0.00 equaled ANGLE'saverage media sentiment score.

Company Overall Sentiment
Abingdon Health Neutral
ANGLE Neutral

ANGLE has a net margin of 0.00% compared to Abingdon Health's net margin of -20.72%. Abingdon Health's return on equity of -48.69% beat ANGLE's return on equity.

Company Net Margins Return on Equity Return on Assets
Abingdon Health-20.72% -48.69% -17.93%
ANGLE N/A -63.75%-29.89%

ANGLE has a consensus target price of GBX 70, suggesting a potential upside of 803.23%. Given ANGLE's higher possible upside, analysts plainly believe ANGLE is more favorable than Abingdon Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Abingdon Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
ANGLE
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

33.5% of Abingdon Health shares are held by institutional investors. Comparatively, 18.8% of ANGLE shares are held by institutional investors. 48.9% of Abingdon Health shares are held by company insiders. Comparatively, 16.2% of ANGLE shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

ANGLE received 182 more outperform votes than Abingdon Health when rated by MarketBeat users.

CompanyUnderperformOutperform
Abingdon HealthN/AN/A
ANGLEOutperform Votes
182
62.33%
Underperform Votes
110
37.67%

Abingdon Health has higher revenue and earnings than ANGLE.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abingdon Health£6.13M2.40-£1.27MN/AN/A
ANGLE£2.02M12.37-£18.03M-£0.07-110.71

Abingdon Health has a beta of 0.13, meaning that its share price is 87% less volatile than the S&P 500. Comparatively, ANGLE has a beta of 0.22, meaning that its share price is 78% less volatile than the S&P 500.

Summary

ANGLE beats Abingdon Health on 7 of the 13 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ABDX vs. The Competition

MetricAbingdon HealthDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£14.69M£17.51M£5.39B£1.58B
Dividend YieldN/A6.10%5.13%11.03%
P/E Ratio-899.002.18113.811,730.79
Price / Sales2.402,474.421,483.25229,524.84
Price / Cash2.254.6039.6435.78
Price / Book7.752.764.662.87
Net Income-£1.27M£59.41M£119.06M£144.63M
7 Day Performance-6.06%-1.47%0.79%0.11%
1 Month Performance-13.89%-7.57%5.65%-0.11%
1 Year Performance-21.16%18.67%36.76%15.22%

Abingdon Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ABDX
Abingdon Health
N/AGBX 7.75
flat
N/A-21.2%£14.69M£6.13M-899.0084Gap Down
AGL
ANGLE
1.6739 of 5 stars
GBX 8
flat
GBX 70
+775.0%
-33.8%£25.80M£2.02M-114.29650
YGEN
Yourgene Health
N/AGBX 0.52
flat
N/AN/A£16.43M£29.67M-51.50253
GDR
genedrive
N/AGBX 2.58
+12.2%
N/A-71.0%£13.99M£49,000.00-64.3843News Coverage
Gap Up
VRCI
Verici Dx
N/AGBX 3.50
flat
N/A-49.8%£8.49M£4.33M-175.0019Negative News
PRM
Proteome Sciences
N/AGBX 2.76
+1.1%
N/A-55.8%£8.15M£4.04M-276.00240Gap Up
GENI
GENinCode
N/AGBX 4
-2.4%
N/A-46.8%£7.08M£2.60M-80.002,300Gap Down
IDHC
Integrated Diagnostics
N/AGBX 0.51
-3.8%
N/A+37.8%£2.98M£4.75B17.106,692Gap Down
LLAI
LungLife AI
N/AGBX 8.55
+0.6%
N/A-91.0%£2.62M£98,566.00-65.7715Gap Down
DMTR
Deepmatter Group
N/AN/AN/A+0.0%£1.33M£1.04M-0.11N/AGap Down
LLA
LLA.L,0P0001T9GN,0
N/AGBX 15
-25.0%
N/AN/A£0.00N/A-125.0015Gap Down
High Trading Volume

Related Companies and Tools


This page (LON:ABDX) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners